Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 178

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 178
---
 the procedures under which services provided by our independent registered public accounting firm will be pre-approved by our Audit
Committee. The potential services that might be provided by our independent registered public accounting firm fall into two categories:

| ● | Services that are permitted, including the audit of our annual financial statements, the review of our quarterly financial statements, related attestations, benefit plan audits and similar audit reports, financial and other due diligence on acquisitions, and federal, state, and non-US tax services; and |

| ● | Services that may be permitted, subject to individual pre-approval, including compliance and internal-control reviews, indirect tax services such as transfer pricing and customs and duties, and forensic auditing. |

Services that our independent registered public
accounting firm may not legally provide include such services as bookkeeping, certain human resources services, internal audit outsourcing,
and investment or investment banking advice.

All proposed engagements of our independent registered
public accounting firm, whether for audit services or permissible non-audit services, are pre-approved by our Audit Committee. We
jointly prepare a schedule with our independent registered public accounting firm that outlines services which we reasonably expect we
will need from our independent registered public accounting firm and categorize them according to the classifications described above.
Each service identified is reviewed and approved or rejected by our Audit Committee.

​

<div align='center'>PART IV</div>

Item 15. Exhibits, Financial Statement Schedules

​

(a) Financial Statements.

The following financial statements are filed as
part of this Form 10-K:

​

| Report of Independent Registered Public Accounting Firm (KPMG LLP, New York, NY; PCAOB ID: 185) 
 Financial Statements:                                                                           
 Balance Sheets as of December 31, 2024 and 2023                                                 
 Statements of Operations for the Years Ended December 31, 2024 and 2023                         | F-2        
 F-4        
 F-5        |
|:------------------------------------------------------------------------------------------------|:-----------|
| Statements of Changes in Stockholders’ Equity for the Years Ended December 31, 2024 and 2023    | F-6        |
| Statements of Cash Flows for the Years Ended December 31, 2024 and 2023                         | F-7        |
| Notes to Financial Statements                                                                   | F-8 - F-29 |

​

(b) Exhibits.

​

| Exhibit No. |   | Description                                                                                                                              |
| 1.1         | ​ | At Market Issuance                                                                                                                       
 Sales Agreement